AAN 2023: Ocrevus for MS found to help Black, Hispanic patients | No new relapses or worse disability seen for 90% for 1 year in trial

More than 90% of Black and Hispanic MS patients experienced no new relapses or disability worsening after one year of Ocrevus treatment.

Related Keywords

Kenya ,Puerto Rico ,United States ,Michigan ,American ,Evanthia Bernitsas ,Genentech ,American Academy Of Neurology ,Multiple Sclerosis Center ,Wayne State School ,American Academy ,Interim Analysis ,Safety Data ,Multiple Sclerosis ,